Statement: FDA Must Reject Tanezumab as a Treatment for Osteoarthritis Due to Unacceptable Dangers, Little to No Benefit
List of Korean firms operating in the United States that would be newly empowered to challenge US policies in foreign tribunals if the Korea FTA went into effect July 1, 2010
Table of Foreign Investor-State Cases and Claims Under NAFTA and Other U.S. “Trade Deals” January 15, 2021
Comments: Regarding U.S. International Trade Commission’s Forthcoming Study on Modifications to the Korea FTA Affecting Passenger Vehicles February 14, 2011